$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT

CRC-P GRANT SECURED BY TESSARA THERAPEUTICS, PSYLO, AND THE UNIVERSITY OF SYDNEY TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION BOULDER, Colo. , Oct. 28, 2024 /PRNewswire/ — Tessara Therapeutics, Psylo, and the University of Sydney are pleased to announce their receipt of a $3…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks